Trial intelligence / Profile preview

Milrinone versus placebo during invasive exercise hemodynamic testing in HFpEF

ACTRN12614000727640Phase 2Recruiting

Sponsor
Alfred Health
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of milrinone, sponsored by Alfred Health. Started Jul 2014; status: recruiting.

02

Drugs

milrinone

Beyond the preview

Go deeper on ACTRN12614000727640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000727640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call